Skip to content

US Launches First Ibogaine Studies For PTSD Treatment In Veterans

Health Secretary Robert F. Kennedy Jr. and Veterans Affairs Secretary Doug Collins announced the initiative on Thursday.

Trump administration will fund new research on controversial psychedelic drug ibogaine. Pic via(@ocregister)

The Trump administration has announced up to $4.9 million in federal funding for the first US studies examining ibogaine as a potential treatment for post-traumatic stress disorder in military veterans.

Health Secretary Robert F. Kennedy Jr. and Veterans Affairs Secretary Doug Collins announced the initiative on Thursday.

💡
The programme follows President Donald Trump's April executive order accelerating psychedelic research. Researchers will also draw on data from Texas-based Beond Inc., which has treated more than 3,000 patients in Mexico.

Ibogaine remains classified as an illegal substance in the United States and carries serious safety risks, including irregular heart rhythms.

Treatment courses at private clinics reportedly cost between $10,000 and $20,000 and require emergency medical monitoring. Officials said additional funding could support research into its potential use for addiction treatment.

Related Tweet:

Also Read:

Trump Urges Senate Republicans To Advance $350 Billion Defense Bill
House Freedom Caucus member Andy Harris defended the proposed increase, arguing that the US needs modern weaponry to fight 21st-century wars.

Comments

Latest